¿¬°£Á¤º¸ ¼­ºñ½º
»óǰÄÚµå
960919

¹Ì±¹ÀÇ ¸Á¸· ½ÃÀå : ºÐ±âº° ¾÷µ¥ÀÌÆ®

Ophthalmic Market Trends: Quarterly US Retina Edition: Q3 - 2024: Analysis of Historical Trends and Latest Developments

¹ßÇàÁ¤º¸: | ¸®¼­Ä¡»ç: Market Scope, LLC | ÆäÀÌÁö Á¤º¸: ¿µ¹®

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¸Á¸·(Retina) ½ÃÀå¿¡ ´ëÇØ ºÐ±âº°·Î ¹Ì±¹ÀÇ ¸Á¸· Àü¹®°¡¸¦ ´ë»óÀ¸·Î Á¶»ç¸¦ ½Ç½ÃÇÏ°í µ¥ÀÌÅ͸¦ ¼öÁýÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú¸¦ ºÐ¼®ÇßÀ¸¸ç, ºÐ±âº°·Î ¹Ý¿µµÇ´Â º¸°í¼­´Â ÇöÀç ½ÃÀå »óȲÀ» Á¤È®ÇÏ°Ô Æò°¡¡¤ÆÄ¾ÇÇÒ ¼ö ÀÖ¾î ÀÇ»ç°áÁ¤ ÇÁ·Î¼¼½º °³¼±À» ¸ñÀûÀ¸·Î Çϰí, ¸Á¸· Ä¡·á, Á¦Ç° »ç¿ë°ú ½ÃÀå Á¡À¯À², Á¦Ç° ä¿ë °èȹ, Àǻ翡 ÀÇÇÑ ÀǾàǰ¡¤¼ö¼ú ±â±¸ Æò°¡ µîÀ» Æ÷ÇÔÇÕ´Ï´Ù.

°¢ °»½Å¿¡´Â ¿¬Áß ¿¹Ãø, Àü³âµµ¿ÍÀÇ ºñ±³, µ¿Ç⠺м®ÀÌ Æ÷ÇԵ˴ϴÙ.

¿¬ 4ȸ, ¹Ì±¹ ¸Á¸· ½ÃÀåÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ÃøÁ¤¡¤ºÐ¼®Çϰí ÀÖ½À´Ï´Ù.

  • Áúȯº° ¹× Á¦Ç°º° À¯¸®Ã¼³»(IVT) ÁÖ»ç
  • Eylea, Lucentis, Avastin, Macugen, Visudyne PDTÀÇ »ç¿ë
  • ´ç´¢º´¼º Ȳ¹ÝºÎÁ¾(DME) Ä¡·á
  • ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå »ç¿ë
  • ±¤ÀÀ°í·®°ú ±¤ÀÀ°íÁ¦ »ç¿ë
  • À¯¸®Ã¼ÀýÁ¦·®°ú À§Ä¡
  • À¯¸®Ã¼ÀýÁ¦±âÀÇ »ç¿ë°ú ½ÃÀå Á¡À¯À²
  • ÀçÀÌ¿ë °¡´É¡¤ÀÏȸ¿ë ±â±¸
  • °¡½ÃÈ­Á¦

°»½Å Á¤º¸¿¡´Â Áö³­ ¸î ³â°£ ¼öÁýµÈ Á¤º¸¿ÍÀÇ ºñ±³¿¡ ±â¹ÝÇÑ µ¿Ç⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ÀÇ ¸Á¸· ¼ö¼ú(IVT ÁÖ»ç Æ÷ÇÔ) ¿¬Áß ¿¹Ãø°ú Àü³â°úÀÇ ºñ±³µµ ½Ç½ÃÇß½À´Ï´Ù.

KSM 20.10.21

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors' evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Contents:

“The Ophthalmic Market Trends: Quarterly US Retina Editions ” measure and analyze key metrics of the US retinal market four times per year, including:

  • IVT injections by disease and product;
  • Use of Eylea, Lucentis, Avastin, Macugen, and Visudyne PDT;
  • DME treatments;
  • Corticosteroid use;
  • Photocoagulation volume and photocoagulators used;
  • Vitrectomy volume and location;
  • Vitrectomy machine use and market share;
  • Reusable and disposable instruments.
  • Visualization agents

Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦